Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial
达格列净治疗伴或不伴2型糖尿病的COVID-19住院患者的疗效和安全性:DARE-19随机试验的预设分析
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02875-6
Abdel Jawad, Mohammad; Furtado, Remo H M; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Langkilde, Anna Maria; Ambery, Philip; Patel, Shachi; Gosch, Kensey; Windsor, Sheryl L; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Javaheri, Ali; Saraiva, J F Kerr; Maia, Lilia Nigro; Berwanger, Otavio; Sauer, Andrew J; Kosiborod, Mikhail N